Kewaunee Scientific Corporation
KEQU
$47.58
-$0.63-1.31%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 47.76M | 48.39M | 56.70M | 46.78M | 50.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.76M | 48.39M | 56.70M | 46.78M | 50.44M |
| Cost of Revenue | 33.81M | 35.91M | 42.06M | 34.75M | 36.97M |
| Gross Profit | 13.95M | 12.49M | 14.64M | 12.03M | 13.47M |
| SG&A Expenses | 9.52M | 9.91M | 13.14M | 8.26M | 8.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.33M | 45.82M | 55.20M | 43.01M | 45.37M |
| Operating Income | 4.43M | 2.58M | 1.50M | 3.77M | 5.07M |
| Income Before Tax | 3.93M | 2.43M | 1.35M | 3.52M | 4.85M |
| Income Tax Expenses | 916.00K | 192.00K | -9.83M | 982.00K | 2.02M |
| Earnings from Continuing Operations | 3.02M | 2.24M | 11.18M | 2.53M | 2.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.00K | -45.00K | -153.00K | -12.00K | -98.00K |
| Net Income | 3.01M | 2.19M | 11.03M | 2.52M | 2.73M |
| EBIT | 4.43M | 2.58M | 1.50M | 3.77M | 5.07M |
| EBITDA | 5.24M | 3.39M | 2.32M | 4.58M | 5.84M |
| EPS Basic | 1.05 | 0.77 | 3.86 | 0.87 | 0.94 |
| Normalized Basic EPS | 0.85 | 0.52 | 0.24 | 0.76 | 1.01 |
| EPS Diluted | 1.01 | 0.74 | 3.71 | 0.85 | 0.93 |
| Normalized Diluted EPS | 0.82 | 0.50 | 0.23 | 0.74 | 1.00 |
| Average Basic Shares Outstanding | 2.87M | 2.85M | 2.86M | 2.89M | 2.90M |
| Average Diluted Shares Outstanding | 2.97M | 2.97M | 2.97M | 2.97M | 2.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
